Anti-Human CXCL13/BLC/BCA-1 MAb (Clone 53610)

データシート※最新のデータシートでない場合があります

• 商品コード：MAB801-500
• メーカー：RSD
• 包装：500μg
• 価格： ¥271,000
• 在庫：無(未発注)

マイリストに追加 マイリストに追加済

• No.： 1
• 文献情報：
  Aqrawi LA et al. Diminished CXCR5 expression in peripheral blood of patients with Sjögren's syndrome may relate to both genotype and salivary gland homing. Clin Exp Immunol 2018 06;192(3):259-270
  Aqrawi LA et al
  2018/01/01
  
• 備考：
  Species: Human, Applications: IHC-P
• 参照：
  

• No.： 2
• 文献情報：
  Thommen DS et al. A transcriptionally and functionally distinct PD-1⁺ CD8⁺ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade. Nat. Med. 2018 Jul;24(7):994-1004
  Thommen DS et al
  2018/01/01
  
• 備考：
  Species: Human, Applications: Flow Cytometry
• 参照：
  

• No.： 3
• 文献情報：
  Panse J et al. Chemokine CXCL13 is overexpressed in the tumour tissue and in the peripheral blood of breast cancer patients. Br. J. Cancer 2008 Sep;99(6):930-8
  Panse J et al
  2008/01/01
  
• 備考：
  Species: Human, Applications: Western Blot
• 参照：
  

• No.： 4
• 文献情報：
  Lisignoli G et al. IL1beta and TNFalpha differently modulate CXCL13 chemokine in stromal cells and osteoblasts isolated from osteoarthritis patients: evidence of changes associated to cell maturation. Exp. Gerontol. 2004 Apr;39(4):659-65
  Lisignoli G et al
  2004/01/01
  
• 備考：
  Species: Human, Applications: IHC-P
• 参照：
  

• No.： 5
• 文献情報：
  Satou A et al. Methotrexate-associated lymphoproliferative disorders of T-cell phenotype: clinicopathological analysis of 28 cases. Mod. Pathol. 2019 Jul;32(8):1135-1146
  Satou A et al
  2019/01/01
  
• 備考：
  Species: Human, Applications: IHC-P
• 参照：
  

• No.： 6
• 文献情報：
  Lisignoli G et al. Hyaluronan-based polymer scaffold modulates the expression of inflammatory and degradative factors in mesenchymal stem cells: Involvement of Cd44 and Cd54. J. Cell. Physiol. 2006 May;207(2):364-73
  Lisignoli G et al
  2006/01/01
  
• 備考：
  Species: Human, Applications: ELISA Development
• 参照：
  

• No.： 7
• 文献情報：
  Edwards KR et al. Feasibility of the use of combinatorial chemokine arrays to study blood and CSF in multiple sclerosis. PLoS ONE 2013;8(11):e81007
  Edwards KR et al
  2013/01/01
  
• 備考：
  Species: Human, Applications: Immuno-PCR
• 参照：
  

• No.： 8
• 文献情報：
  Muto R et al. Epidemiology and secular trends of malignant lymphoma in Japan: Analysis of 9426 cases according to the World Health Organization classification. Cancer Med 2018 Nov;7(11):5843-5858
  Muto R et al
  2018/01/01
  
• 備考：
  Species: Human, Applications: IHC
• 参照：
  

• No.： 9
• 文献情報：
  Asai A et al. Host antitumor resistance improved by the macrophage polarization in a chimera model of patients with HCC. Oncoimmunology 2017;6(4):e1299301
  Asai A et al
  2017/01/01
  
• 備考：
  Species: Human, Applications: ICC
• 参照：
  

• No.： 10
• 文献情報：
  Klimatcheva E et al. CXCL13 antibody for the treatment of autoimmune disorders. BMC Immunol. 2015;16:6
  Klimatcheva E et al
  2015/01/01
  
• 備考：
  Species: Human, Applications: Direct ELISA
• 参照：
  

• No.： 11
• 文献情報：
  B端rkle A et al. Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia. Blood 2007 Nov;110(9):3316-25
  B端rkle A et al
  2007/01/01
  
• 備考：
  Species: Human, Applications: IHC-P
• 参照：